4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]. It belongs to telmisartan intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole. It belongs to telmisartan intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(3-methylphenyl)amino-3-pyridine sulphonamid. It belongs to torsemide intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate. It belongs to gemifloxacin intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1. It belongs to lornoxicam intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]. It belongs to gemifloxacin intermediates products category. Contact us for more inf...

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abacavir sulphate. It belongs to antiretroviral apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abiraterone. It belongs to anticancer apis category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.